Analystreport

Blueprint Medicines Corp (NASDAQ: BPMC) is now covered by analysts at JMP Securities. They set an "outperform" rating and a $106.00 price target on the stock.

Blueprint Medicines Corporation  (BPMC) 
Last blueprint medicines corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: blueprintmedicines.com